Effects of medium-chain fatty acids and their acylglycerols on the transport of penicillin V across Caco-2 cell monolayers

Bioscience, Biotechnology and Biochemistry

Volumn 61, Issue 7, 1997, Pages 1150-1155

  Shima, Motohiro ^a,b   Yohdoh, Kaori ^a   Yamaguchi, Masayo ^a   Kimura, Yukitaka ^a   Adachi, Shuji ^a   Matsuno, Ryuichi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b JUSCG Co   (Japan)

Author keywords

Caco 2; Medium chain fatty acids and acylglycerols; Physico chemical property; Surface activity; Transepithelial transport

Indexed keywords

ACYLGLYCEROL; FATTY ACID; PENICILLIN V; SURFACTANT; TAUROCHOLIC ACID; TRIACYLGLYCEROL; VOLATILE FATTY ACID;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CHEMISTRY; DRUG EFFECT; ELECTRIC CONDUCTIVITY; ELECTRON MICROSCOPY; EPITHELIUM; HUMAN; METABOLISM; PHYSIOLOGY;

CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; ELECTRIC CONDUCTIVITY; EPITHELIUM; FATTY ACIDS; FATTY ACIDS, VOLATILE; GLYCERIDES; HUMANS; MICROSCOPY, ELECTRON; PENICILLIN V; SURFACE-ACTIVE AGENTS; TAUROCHOLIC ACID; TRIGLYCERIDES;

EID: 0031183655     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.61.1150     Document Type: Article

References (24)

1. M. Chanez, B. Bois-Joyeux, M. J. Arnaud, and J. Peret, J. Nutr., 121, 585-594 (1991).
2. N. Hayashi, T. Nakamura, D. Yoshihara, M. Yanai, and G. Kawanishi, J. Jpn. Soc. Nutr. Food Sei. (in Japanese), 44, 385-390 (1991).
3. N. Muranishi, E. Mack, and S. W. Kim, Drug Dev. and Ind. Pharm., 19, 929-941 (1993).
4. K. Nishimura, Y. Nozaki, A. Yoshimi, S. Nakamura, M. Kitagawa, N. Kakeya, and K. Kitao, Chem. Pharm. Bull, 33,282-291 (1985).
5. N. Yata, Y. Higashi, T. Murakami, P. Yamajo, W. M. Wu, K. Taku, Y. Sasaki, and Y. Hideshima, J. Pharmacobio-Dyn., 6, s-78 (1983).
6. M. Tomita, M. Hayashi, and S. Awazu, J. Pharmacol. Exp. Ther., 272, 739-743 (1995).
7. H. Yoshitomi, T. Nishihata, G. Frederick, M. Dillsaver, and the late T. Higuchi, J. Pharm. Pharmacol, 39, 887-891 (1987).
8. M. Sekine, K. Sasahara, T. Kojima, K. Hasegawa, R. Okada, and S. Awazu, J. Pharm. Dyn., 7, 856-863 (1984).
9. M. Tomita, M. Hayashi, and S. Awazu, Biol. Pharm. Bull, 17, 753-755 (1994).
10. E. K. Anderberg, T. Lindmark, and P. Artursson, Pharm. Res., 10, 857-864 (1993).
11. R. Matsuno and S. Adachi, Trends in Food Science & Technology, 4, 256-261 (1993).
12. P. Artursson, Crit. Rev. Ther. Drug Carrier Syst., 8, 305-330 (1991).
13. K. Hashimoto, N. Matsunaga, and M. Shimizu, Biosci. Biotech. Biochem., 58, 1345-1346 (1994).
14. H. Daniel, B. Neugebauer, A. Kratz, and G. Rehner, Am. J. Physiol., 248 (Gastrointest. Liver Physiol., 11), G293-G298 (1985).
15. J. Karlsson and P. Artursson, Biochim. Biophys. Acta, 1111, 204-210 (1992).
16. L. Wilhelmy, Ann. Physik., 119, 177 (1863).
17. E. K. Anderberg, C. Nyström, and P. Artursson, J. Pharm. Sei., 81, 879-887 (1992).
18. J. T. Davis and E. K. Ridal, in “Interface Phenomena,” Academic Press, New York, 1961, p. 359.
19. E. J. Van Hoogdalem, A. G. De Boer, and D. D. Breimer, Pharmac. Ther., 44, 407-443 (1989).
20. M. Gibaldi and S. Feldman, J. Pharm. Sei., 59, 579-589 (1970).
21. W. F. Stenson, R. A. Easom, T. E. Riehl, and J. Turk, Am. J. Physiol., 265 (Gastrointest. Liver Physiol., 28), G955-G962 (1993).
22. M. S. Baida, L. Gonzälez-Mariscal, R. G. Contreras, M. Macias-Silva, M. E. Torres-Marquez, J. A. G. Säinz, and M. Cereijido, J. Membrane Biol, 122, 193-202 (1991).
23. S. Citi, J. Cell Biol, 117, 169-178 (1992).
24. E. G. Lapetina, B. Reep, B. R. Ganong, and R. M. Bell, J. Biol. Chem., 260, 1358-1361 (1985).